Compliance with maintenance treatment of asthma (ADERE study);Adesão ao tratamento de manutenção em asma (estudo ADERE)

Jornal Brasileiro de Pneumologia

Volumn 32, Issue 4, 2006, Pages 277-283

  Chatkin, José Miguel ^a,b,d   Cavalet Blanco, Daniela ^a   Scaglia, Nóris Coimbra ^a   Tonietto, Roberto Guidotti ^a   Wagner, Mário B ^a,c   Fritscher, Carlos Cezar ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF LONDON   (United Kingdom)

^d University of London ^*  (Brazil)

Author keywords

Asthma drug therapy; Asthma prevention control; Patient compliance; Patient education; Physician patient relations

Indexed keywords

EID: 33846266208     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132006000400004     Document Type: Article

References (39)

1. Chung KF, O'Byrne P. Pharmacological agents used to treat asthma, In: Chung KF, Fabbri L, editors. Asthma. Sheffield, UK: European Respiratory Society; 2003. p. 339-75.
2. Sabaté E, editor. Adherence to long-term therapies: evidence for action [monography on the Internet]. Geneva: World Health Organization; 2003. [cited 2005 Jul 17]. Available from: http://www.who.int/chronic_conditions/en/ adherence_report.pdf
3. Sociedade Brasileira de Pneumologia e Tisiologia. I Consenso Brasileiro no Manejo da Asma. J Pneumol. 2002;28 Supl 1:S1-S28.
4. Sawyer SM, Aroni RA. Sticky issue of adherence. J Pediatr Child Health. 2003;39(1):2-5.
5. Clepper I. Noncompliance: the invisible epidemic. Drug Topics. 1992;136(17):44-65.
6. Williams LK, Pladevall M, Xi H, Joseph C, Lafata JE, Ownby DR, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288-93.
7. Adams RJ, Fuhlbridge A, Guilbert T, Lozano P, Martinez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol. 2002;110(1):58-64.
8. Taylor DM, Auble TE, Calhoun WJ, Monsesso VN Jr. Current outpatient management of asthma shows poor compliance with international consensus guidelines. Chest. 1999; 116(6):1638-45.
9. Comment in: Chest. 1999;116(6):1509-10.
10. Sabaté E. The magnitude of the problem of poor adherence. In: Sabaté E, editor.. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. p. 7-9.
11. National Institute of Health, National Heart Lung and Blood Institute. Guidelines for the diagnosis and management of asthma. Washington, DC: 1999.
12. Partridge MR, Barnes G. Health professional and patient education, In: Clark TJH, Godfrey S, Lee TH, editors. Asthma. London, UK: Arnold Publishers; 2000. p. 426.
13. Chatkin JM, Menna Barreto S, Fonseca NA, Gutierrez CA, Sears MR. Trends in asthma mortality in young people in southern Brazil. Ann Allergy Asthma Immunol. 1999;82(3):287-92.
14. Comment in: Ann Allergy Asthma Immunol. 1999;83(6 Pt 1):572-3.
15. Lotufo PA, Benseñor IJM, Lolio CA. Mortality from asthma in the state of S.Paulo, Brazil (1970-1992). Rev Saúde Pública. 1995;29(6):434-9.
16. Naspitz CK, Solé D, Salto JJ. Beta 2-agonists and death from asthma. J Allergy Clin Immunol. 1994;93(3):677-8.
17. Solé D, Yamada E, Vana AT, Costa Carvalho BT, Naspitz CK. Prevalence of asthma and related symptoms in school-age children in Sao Paulo, Brazil - International Study of Asthma and Allergies in Children (ISAAC). J Asthma. 1999;36(2):205-12.
18. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351(9111):1225-32.
19. Comment in: Lancet. 1998;351(9111):1220-1;
20. Lancet. 2001;357(9252):313-4.
21. Brasil. Ministério da Saúde. MERCOSUL. Grupo Mercado Comum do Sul. Resolução no 129/96. Boas práticas clínicas. Boas práticas de pesquisa de farmacologia clínica. [texto na Internet]. Brasília: Ministério da Saúde. [citado 2005 Set 9]. Disponível em: http://www.bioetica.ufrgs.br/bpcmerco.htm .
22. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. E6(R1) Guideline for good clinical practice [monograph on the Internet]. Geneva: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 1996 [cited 2005 Sept 29]. Available from: http://www.ich.org/ LOB/media/MEDIA482.pdf
23. Rand CS. Non-adherence with asthma therapy: more than just forgetting. J Pediatr. 2005;146(2):157-9.
24. Comment in: J Pediatr. 2005;146(2):171-6.
25. Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, Chinchilli VM, Craig TJ, Dimango EA, Deykin A, Fagan JK, Fish JE, Ford JG, Kraft M, Lemanske RF Jr, Leone FT, Martin RJ, Mauger EA, Pesola GR, Peters SP, Rollings NJ, Szefler SJ, Wechsler ME, Israel E; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005;352(15):1519-28.
26. Comment in: ACP J Club. 2005;143(3):60.
27. N Engl J Med. 2005;352(15):1589-91.
28. N Engl J Med. 2005;353(4):424-7; author reply 424-7.
29. Fabbri LM. Does mild persistent asthma require regular treatment? N Engl J Med. 2005;352(15):1589-91.
30. Comment in: N Engl J Med. 2005;352(15):1519-28.
31. Weinstein AG. Should patients with persistent severe asthma be monitored for medication adherence? Ann Allergy Asthma Immunol. 2005;94(2):251-7.
32. Cabral AL, Carvalho WA, Chinen M, Barbiroto RM, Boueri FM, Martins MA. Are international asthma guidelines effective for low-income Brazilian children with asthma? Eur Respir J. 1998;12(1):35-40.
33. Chatkin JM, Zaslavski C, Orlandini L, Zagoury EL, Scliar MJ. A inclusão da asma brônquica nos programas de controle de doenças respiratórias agudas. J Pneumol. 1986;12(3):167-9.
34. Chatkin M, Menezes AMB, Albernaz E, Victora C, Barros FC. Fatores de risco para consultas em pronto-socorro por crianças asmáticas no sul do Brasil. Rev Saúde Pública 2000;34(5):491-8.
35. O'Connell EJ. Optimizing inhaled corticosteroid therapy in children with chronic asthma. Pediatr Pulmonol. 2005;39(1):74-83.
36. Cabana MD, Rand CS, Becher OJ, Rubin HR. Reasons for pediatrician non-adherence to asthma guidelines. Arch Pediatr Adolesc Med. 2001;155(9):1057-62.
37. Kravitz RL, Hays RD, Sherbourne CD, DiMatteo MR, Rogers WH, Ordway L, et al. Recall of recommendation and adherence to advice among patients with chronical medical conditions. Arch Intern Med. 1993;153(16):1869-78.
38. Krishnan JA, Riekert KA, McCoy JV, Stewart DY, Schmidt S, Chanmugan A, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med. 2004;170(12):1281-5.
39. Meichenbaum D, Turk DC. Treatment adherence: terminology, incidence and conceptualization, In: Meichenbaum D, Turk DC, editors. Facilitating treatment adherence. New York: Plenum Press; 1987. p. 19-39.